Talk:Comedocarcinoma

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

External links modified[edit]

Hello fellow Wikipedians,

I have just modified one external link on Comedocarcinoma. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at {{Sourcecheck}}).

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

  • If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
  • If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 13:43, 28 November 2016 (UTC)[reply]

Contradiction in article on Comedocarcinoma[edit]

Hello Fellow Wikipedians,

I hope someone can address the contradictory statements in this section of the article:

Clinical Relevance[edit]

Pathology[edit]

Comedocarcinomas are known as the most aggressive form of intraductal carcinomas, although they are considered to be an early stage of breast cancer and are classified as noninvasive.

Individuals diagnosed with comedo-type DCIS (comedocarcinoma) often have a higher chance of it developing into an invasive derivative—if left untreated, this chance is nearly 100%. These individuals are also at an increased risk of cancer recurrence, with this recurrence manifesting itself earlier than in other forms of DCIS. The prognosis for comedocarcinoma is usually favorable with treatment intervention (i.e. surgery, radiotherapy, or hormone therapy); leading to a lower risk of invasive carcinoma development.

While it is uncommon for these tumors to evolve into invasive carcinomas, there have been a few reported incidents of such cases.[citation needed]


So is it nearly 100% will develop into invasive cancer, or is it uncommon? Ann Marie Maher (talk) 15:47, 29 July 2022 (UTC)[reply]